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Background: Many Type 2 Diabetes Mellitus (T2DM) patients refuse insulin therapy even when they require this
modality of treatment. However, some eventually accept insulin. This study aimed to explore the T2DM patients’
reasons for accepting insulin therapy and their initial barriers to use insulin.
Methods: This qualitative study interviewed twenty-one T2DM patients at a primary care clinic who had been on
insulin for more than a year through three in-depth interviews and three focus group discussions. A semi structured
interview protocol was used and the sessions were audio-recorded. Subsequently, thematic analysis was conducted
to identify major themes.
Results: The participants’ acceptance of insulin was influenced by their concerns and beliefs about diabetes and
insulin. Concerns about complications of poorly controlled diabetes and side effects of other treatment regime had
resulted in insulin acceptance among the participants. They also had a strong belief in insulin benefits and
effectiveness. These concerns and beliefs were the results of having good knowledge about the diabetes and
insulin, experiential learning, as well as doctors’ practical and emotional support that helped them to accept insulin
therapy and become efficient in self-care management. These factors also allayed their negative concerns and
beliefs towards diabetes and insulin, which were their barriers for insulin acceptance as it caused fear to use insulin.
These negative concerns were related to injection (self-injection, needle phobia, injection pain), and insulin use
(inconvenience, embarrassment, lifestyle restriction, negative social stigma, and poor self-efficacy), whereas the
negative beliefs were ‘insulin could cause organ damage’, ‘their diabetes was not serious enough’, ‘insulin is for life-
long’, and ‘insulin is for more severe disease only’.
Conclusions: Exploring patients’ concerns and beliefs about diabetes and insulin is crucial to assist physicians in
delivering patient-centered care. By understanding this, physicians could address their concerns with aim to modify
their patients’ misconceptions towards insulin therapy. In addition, continuous educations as well as practical and
emotional support from others were found to be valuable for insulin acceptance.
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Early use of insulin in the management of poorly con-
trolled diabetes has been recommended to prevent and
reduce the long-term diabetes complications [1,2]. It re-
duces patients’ exposure to prolonged hyperglycemia,
which ultimately increases risks of diabetes-related com-
plications [3]. However, delay in insulin initiation is
common. About 50% of patients with poor control
T2DM did not timely start insulin therapy and the initi-
ation was usually three to five years after failure of oral
hypoglycemic agents [4,5]. There are many factors influ-
encing delayed insulin initiation including those caused
by healthcare providers and its system, as well as the
patients themselves [6-8]. One of the main barriers is
psychological insulin resistance (PIR), defined as psycho-
logical opposition towards insulin use, among patients
and healthcare providers [7,9,10].
About 27% of the UKPDS patients allocated to insulin
therapy was found to have refused insulin [11]. Even
among insulin-naïve diabetes patients in the Western
community, a comparable proportion (28-39%) was re-
luctant to be on insulin [12-14]. However, higher pro-
portion of PIR was reported by Asian studies, quoting
prevalence between 51–70.6% [15,16].
Gherman et al. (2011) had reviewed 60 literatures on
PIR and summarised factors for PIR into four main
categories [10]: (1) emotional factors (e.g. fear of injec-
tion pain and needle, apprehension of self-injection, fear
of injection technique or correct dosing, and fear of
consequences of insulin use, such as hypoglycaemia,
weight gain, lifestyle restriction, and inconvenience)
[13-15,17,18], (2) cognitive factors (e.g. perception of
poor self-efficacy, personal failure or ineffectiveness of
insulin, belief that own diabetes is not serious enough,
and insulin is for more severe diabetes) [15,17-20], (3)
social/cultural factors (e.g. social stigma and embarrass-
ment) [15,20,21], and (4) relational factors (e.g. influence
by others particularly health care providers) [18,22,23].
Physical factors (e.g. pain or bruising due to injection)
also cause insulin refusal among those who have agreed
to take insulin, resulting in omission or skipping of insu-
lin [13,15,17,18].
In general, PIR has been extensively examined through
reviews, perspectives in practice, editorials, as well as
quantitative and qualitative studies [10]. Based on previ-
ous PIR studies, the insulin-naïve diabetes patients who
were more willing to accept insulin therapy were males,
and those with tertiary education, insulin-using relatives,
more diabetes-related complications, strong self-efficacy
and better relationship with their healthcare providers
[14-16,23]. They have more positive perceptions about
insulin in term of its effectiveness in improving their gly-
cemic control and general health, as well as preventing
diabetes complications [14-16,23]. Woundenberg et al.(2012) also found that these patients were less likely to
oppose to lifelong insulin therapy, which was related to
their confidence in beneficial effects of insulin [14].
Perceiving insulin as beneficial is a crucial factor for
diabetes patients commencing on insulin to accept insu-
lin therapy [24,25]. It is influenced by how important
good glycemic control to them and their confidence that
insulin could help them achieving it [25]. Their expect-
ation and understanding that good glycemic control im-
proves their health and well being also shape their
perception [25,26]. As described by Morris et al. (2005),
diabetes patients identified insulin as a ‘friend’ or ‘foe’
and this influenced their coping with the therapy [24].
Experience of using insulin over time had helped them
to rationalise the benefits and accept insulin as ‘a friend’
[24]. The experience empowered their confidence to use
insulin by learning that they were able to injecting them-
selves and adjusting the insulin dose [24]. It allowed
demonstration of insulin efficacy through achieving bet-
ter glycemic control and well beings, thus validating
their perception of insulin benefits [24].
On-going experience with treatments through experi-
mentation and discussions with healthcare providers has
been found to influence diabetes patients in deciding
what works for them [26]. They did not consciously
assess benefits and risks of a treatment at the point of
its commencement; instead their treatment decision-
making was a continuous process [26]. In a study by
Phillips (2007), the participants who had been taking in-
sulin for at least one year described that their experience
was far less traumatic than what they had expected [27].
Many of them felt healthier after insulin initiation [27].
They were able to cope with insulin use and could man-
age their diabetes well [27].
Due to limited number of studies exploring diabetes pa-
tients’ experience taking insulin, our understanding about
how and why patients accept insulin is still unclear. Many
studies have focused on the patients’ difficulties taking in-
sulin, their coping mechanism and perceptions on insulin.
Furthermore, the studies were carried out in western
countries that commonly practice independent individual-
ism culture. In contrast to Asian countries, which have
more dependent collectivism culture. These different types
of culture play an important role in influencing diabetes
patients’ belief and attitude towards their health and
health behaviour. Studying the factors influencing insulin
acceptance is crucial to formulate effective strategies for
insulin initiation. A qualitative approach allows detailed
exploration of experience, feelings, beliefs and attitude of
the diabetes patients in the context of insulin acceptance.
Thus, this study aimed to explore factors that influence
T2DM patients in Malaysia to accept insulin. Their bar-
riers towards insulin use which they experienced prior in-
sulin initiation was also explored.
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This qualitative study involved twenty-one T2DM pa-
tients who had been on insulin for one year or more
(Table 1). The participants were purposively selected
from those who had been attending a primary care clinic
in Kuala Lumpur from February 2009 to January 2010.
Patients who were assumed to be able to generate rich,
thick and meaningful information based on their experi-
ence, reminiscence and ability were invited to participate
in this study. They were from different age groups, eth-
nicity, gender, and socioeconomic status. They also had
various duration of diabetes and duration of insulin use.
This was to ensure heterogeneity of the data. Patients
with history of serious medical condition at the time of
insulin initiation and those who could not communicate
in either Bahasa Malaysia or English were excluded. The
sample size of the study was determined when data sat-
uration was reached. This was taken as the point at
which redundancy of information occurred or when no
more new information was expected to emerge [28].Table 1 The characteristics of the participants
In depth
interview
Focus group discussion
(IDI 1, 2 & 3) (FGD 1, 2 & 3)
(n = 3) (n = 18)
Age (year) 58–67 40–68
Ethnicity
Malay 1 10
Chinese - 4
Indian 2 4
Gender
Female 1 7
Male 2 11
Educational
status*
Primary level 1 8
Secondary level 1 5
Tertiary level 1 5
Duration of
diabetes (year)
8–13 5–14
Duration of insulin
use (year)
3–4 2–6
Occupations Retiree,
lecturer,
housewife
Housewife, chef, police officer,
government officer, retired
businessman, security officer,
teacher, retired nurse, clerk, retired
army, retired contractor, insurance
agent, businessman, engineer,
driver
*Educational status: Primary = schooling from age 7–12 years old.
Secondary = schooling up to age 17 years old.
Tertiary = schooling up to college or university level.After obtaining the informed consents, the participants
were interviewed either individually (in-depth interviews
(IDIs)) or in groups (focus group discussions (FGDs))
(Table 1). All interviews were moderated by the main re-
searcher, a postgraduate student of family medicine who
received training in qualitative research. The interviews
were carried out at the primary care clinic where the
participants received their care. Educational status of the
diabetes patients had been the basis of sampling in this
study as it was hypothesised to influence their attitude
towards insulin. Furthermore, grouping the patients for
FGD according to their educational status could facili-
tate data generation. To optimise rigour of the study,
discussions with both homogeneous and heterogeneous
focus groups in term of educational status were per-
formed. Participants with similar educational status
would feel less intimidated to share their experience and
opinion and this could allow in-depth discussion of is-
sues. Therefore, in this study, homogeneity of a group
was ensured in two of the FGDs. However, using this re-
cruitment approach could result in biased findings and
limited information gained from such groups [29]. Since
this study was exploratory in nature, maximising range
of opinion was crucial. Therefore, participants with vari-
ous educational status were grouped in one of the FGDs
to allow generation of rich data. The session was moder-
ated by a trained personnel to assist in free sharing of
opinion and experience in a heterogeneous group.
Each interview was conducted over one and a half hour,
using a semi-structured interview protocol (Table 2).
Many of the participants were bilingual, hence they were
allowed to converse in Bahasa Malaysia or English, de-
pending on their preference. A standard protocol was
developed to explore the reasons for acceptance of insulin.
The participants were allowed to discuss their feelings and
perception regarding insulin when its use was first
recommended. During the interview, the participants’ re-
sponses to the main questions (as in the protocol) were
followed to expand their comments and explore the issues
in depth through probing, rephrasing, and clarifying. AllTable 2 Interview protocol used in the in-depth
interviews and group discussions
Main issues Questions
Initial feelings when insulin was
first suggested
Question 1: How did you feel when
you were first told to start on insulin
therapy? Explore
Initial perception or belief
about insulin
Question 2: What was your perception
about insulin at that time? Explore
Factors influencing insulin
acceptance
Question 3: Why did you accept
insulin therapy? Explore
Perception or belief about
insulin when accepting insulin
Question 4: What was your perception
about insulin at the time when you
agree to use insulin? Explore
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video recording was necessary to assist in identifying the
participants in the audio-recordings.
After each interview, the audio recording was tran-
scribed and the transcript was examined against the ac-
tual recordings to ensure accuracy. Thematic analysis
was performed using NVIVO 7 (QSR International Pty
Ltd, Victoria, AU) to identify themes found in each tran-
script. Eventually, all themes were categorised into three
major themes. These were: (1) participants’ feelings to-
wards insulin use, (2) their perception about insulin, and
(3) their reasons for accepting insulin. To ensure the re-
liability and accuracy of the coding process, two other
researchers crosschecked the coding of the data.
Ethical issues, reliability, and validity
This study received ethical approval from the Research
and Ethic Committee of the Universiti Kebangsaan
Malaysia and permission to perform the study at
the University Primary Care Clinic was obtained. In
addition, all participants provided written consents prior
to their interviews and their identities were preserved to
ensure confidentiality.
To ensure reliability and validity of the study, several
strategies were implemented: (1) triangulation of data col-
lection through three IDIs and three FGDs, (2) self-
reflectivity and peer review or debriefing, (3) procedural
validity through proper interview technique, and (4) cross-
checking of the coding process in the thematic analysis.
Results
Sociodemographic characteristics of the participants
Twenty-one T2DM patients were interviewed through
three in-depth interviews (IDIs) and three focus group
discussions (FGDs). Data saturation was reached during
the last three interviews (two IDI and one FGD).
There were 8 female and 13 male participants; 11
Malays, 4 Chinese and 6 Indians. Their age ranged be-
tween 40 to 68 years old (Table 1). The average duration
of having diabetes was 8 years and the average duration
of insulin use was 3.2 years.
Participants’ feelings when insulin use was first
recommended
Many participants had negative concerns related to insu-
lin use. The main concerns vented by them were about
injection of insulin:
(1) Painful injection.“I am scared of needle.. you know, the poking itself,
it is painful.. using needle some more, and you poke
yourself.. it is painful” (3 years of insulin use/ 6 years
of having diabetes).“Injection is painful” (3 years of insulin use/ 6 years
of having diabetes).(2) Apprehension about self-injection.“I could not do it myself. I could not poke myself like
that. The fear of injecting myself when the doctor
asked me to use insulin.. Urgghhh.. I dared not” (2.5
years of insulin use/ 6 years of having diabetes).“I never had anything against insulin but I could not
seeing myself to inject insulin” (4 years of insulin use/
10 years of having diabetes).(3) Needle phobia.“I have phobia of needles. Last time, they used quite a
long needle.” (3 years of insulin use/ 6 years of having
diabetes).(4) Social embarrassment.“Sometimes it is embarrassing to inject insulin in
public places like restaurants.” (6 years of insulin use/
14 years of having diabetes).“It is not easy when people watch you injecting
insulin. It is embarrassing” (2 years of insulin use/ 5
years of having diabetes).
Apart from concerns related to injection, the partici-
pants were worried about the impacts of using insulin:
(1) Inconvenience and impractical.“I see half an hour before dinner she (my daughter-in
law’s mother) has to inject.. I said..so troublesome,
very inconvenient” (2.5 years of insulin use/ 6 years of
having diabetes).“I don’t think using needle is practical” (3 years of
insulin use/ 6 years of having diabetes).(2) Lifestyle restriction.“When you are on insulin, it is more difficult to go
out or eat out. You are more restricted. You have to
plan your exercise as well” (6 years of insulin use/ 10
years of having diabetes).(3) Social stigma.“Our society is quite ignorant of insulin therapy and
they might associate insulin injection with drug
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diabetes).
In addition, they had concerns with their own ability
to manage insulin use and one participant claimed it
was due to poor counselling by the HCP:
“I was not confident to handle the injection, use the
needle, the timing… I was not confident” (4 years of
insulin use/ 10 years of having diabetes).“When I was first prescribed insulin, I was not
counselled properly. Nobody gave me proper
explanation on how and when to administer insulin,
how to look after insulin pens and how to overcome
hypoglycaemia. I had some doubts and was not very
confident to start insulin therapy” (4 years of insulin
use/ 10 years of having diabetes).Participants’ perception about insulin when it was first
recommended
The participants in this study admitted to have certain
perception about insulin that resulted in their reluctance
to use insulin. They believed that:
(1) Insulin causes organ damage.“When the doctor prescribed insulin, I was terrified of
detrimental effects of insulin on kidneys. I was afraid
that insulin might ruin my health” (3 years of insulin
use/ 5 years of having diabetes).(2) Insulin is not indicated as their diabetes is regarded
as not serious enough.“When I first heard of insulin, I was made to
understand that your disease is very serious when you
need insulin. That was why I refused insulin initially. I
did not want to be in a very serious category” (3 years
of insulin use/ 8 years of having diabetes).(3) Insulin is only for severe diabetes.“My friends and siblings told me that people who
received insulin were very serious. They might die
soon” (3 years of insulin use/ 5 years of having
diabetes).(4) Insulin is for life-long.“Because I know insulin is something that you have to
live with for the rest of your life. You cannot go off
insulin” (2 years of insulin use/ 8 years of having diabetes)Impacts of the participants’ initial feelings and perception
on insulin use
Many participants were reluctant to use insulin when
their doctors first recommended insulin. Their concerns
and negative perception about insulin had resulted them
to have fear to use insulin:
“I was actually scared of insulin because it requires
injection” (2 years of insulin use/ 10 years of having
diabetes).“I was scared of insulin injection” (2 years of insulin
use/ 5 years of having diabetes).
Factors for insulin acceptance
Similarly as described by the participants for their initial
insulin resistance, their concerns and beliefs about dia-
betes and insulin had played important factors in their
treatment decision-making. In this study, the partici-
pants admitted that their concerns about the complica-
tions of poorly controlled diabetes and side effects of
other treatment regime made them to accept insulin:
“I agreed to take insulin after the doctor informed me
that high blood sugar could cause stroke and kidney
failure. So when I heard about the risk of having a
stroke, I was scared.” (3 years of insulin use/ 10 years
of having diabetes).“Furthermore, the (oral) medications can cause kidney
damage” (5 years of insulin use/ 10 years of having
diabetes).
Their beliefs about insulin and other diabetes treatment
had triggered them to accept insulin use, including:
(1) Insulin is effective treatment to improve their
health, maintain good glycemic control or prevent
complications.“I know insulin makes you healthier and more
energetic. That’s why I took it” (3 years of insulin use/
12 years of having diabetes).“I know insulin is good. Sugar control becomes better
and you have better quality of life. At the end of the
day, you just want to have a good life, right… not just
physical, but your mental and soul as well” (2.5 years
of insulin use/ 6 years of having diabetes).“To me, insulin is good for our health because it
can control blood sugar and prevent amputation
and dialysis” (2 years of insulin use/ 5 years of
having diabetes).
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is why (this) information is very important to ease the
acceptance to insulin therapy” (3 years of insulin use/
8 years of having diabetes).(3) Limited benefits of oral hypoglycemic agents.“I accepted insulin because the pills were not effective
anymore. Pills are not effective in long standing
diabetes, not effective in controlling diabetes… not
effective anymore” (6 years of insulin use/ 10 years of
having diabetes).“I know after a while, oral medication cannot bring
down blood sugar. I took insulin because the pills
were not working anymore” (5 years of insulin use/ 2
years of having diabetes).
The participants claimed that their subsequent positive
attitude towards insulin use was a result of having good
knowledge about diabetes and its treatment, obtained
through reading, surfing internet and their relatives:
“I gained a lot of knowledge from self-reading and
relatives who are on insulin” (2 years of insulin use/ 5
years of having diabetes).“I read a lot about insulin, I surf internet. That’s why I
know about the benefits of insulin” (3 years of insulin
use/ 8 years of having diabetes).“I always refer to these two ‘specialists’ (my father and
older brother who are on insulin) when it comes to
insulin” (6 years of insulin use/ 10 years of having
diabetes).
The participants also admitted to accept insulin
through learning about benefits of insulin from other
people’s experience (experiential learning):
“After I saw my husband had better sugar control
with insulin, I accepted insulin” (5 years of insulin
use/ 2 years of having diabetes).“How could I refuse insulin? My father and older
brother are on insulin. My brother’s health was better
after he took insulin.” (6 years of insulin use/ 10 years
of having diabetes).
They affirmed that their acceptance became stron-
ger as they personally experienced the benefits of in-
sulin in terms of improved general health, well-beingand self-care behaviour after they started using the
insulin:
“It feels different to be on insulin. I feel better when I
use insulin. I used to have blurred vision before using
insulin. Now I have good vision” (3 years of insulin
use/ 8 years of having diabetes).“When I was on oral treatment, I was always sleepy
and tired. After taking insulin, I become more
energetic and more confident in life” (3 years of
insulin use/ 12 years of having diabetes).“When I’m on insulin, I became more concerned of
my health. I will check my sugar two or three times
per day. I notice that the sugar will rise if I do not
take insulin. I become more careful with food intake
and do more exercise” (5 years of insulin use/ 2 years
of having diabetes).
Furthermore, the participants admitted that good rela-
tionship with their doctors had prepared them to use in-
sulin. Effective communication (e.g. polite and clear
explanation), relationship with respect and trust, as well
as patient-centred counselling, were specifically men-
tioned by the participants as their reasons to accept
insulin:
“When the doctor advised me to start insulin therapy,
I felt embarrassed to reject his recommendation. The
doctor was ‘cool’, never angry; talked nicely and that
made me feel so comfortable. After such thorough
explanation, any patient will be embarrassed to say no
to insulin.” (4 years of insulin use/ 8 years of having
diabetes).“When the doctor advised me to start on insulin, the
explanation was clear” (2 years of insulin use/ 5 years
of having diabetes).“You accept the insulin because the bond is there and
you respect him (doctor)” (4 years of insulin use/ 8
years of having diabetes).“I accepted insulin because I listened to the doctor.
The doctor advised me to take insulin as it can
improve my blood sugar. Whatever he (doctor) says, I
will follow because I trust him” (3 years of insulin
use/ 6 years of having diabetes).“..we discussed about the issues of insulin, my worries
and thoughts about insulin. I became less apprehensive
and was ready to start on insulin therapy” (2 years of
insulin use/ 5 years of having diabetes).
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Generally, both positive and negative concerns and
beliefs about diabetes and insulin were the basis of the
participants’ decision to use insulin in this study. Ini-
tially, many participants were reluctant to use insulin
as a result of their negative concerns about insulin
injection. This anxiety related to injection (i.e. fear
of injection pain or needle) is actually very common
among diabetics, reported as high as 71% among insulin
naive diabetics [13,15,16,24,30,31]. Morris et al. (2005)
highlighted possible relation between needle phobia and
the needle size [24]. Thus, use of thinner and shorter
needles could reduce this fear, making injection less
painful. However, Snoek et al. (2007) found that a sub-
stantial proportion of diabetes patients who were treated
with insulin (38%) using thinner needles still admitted
“Injecting insulin is painful” [31]. This proportion was
not far from those who were insulin naïve (43%), though
the difference was found significant [31]. Despite this
finding, a striking drop in fear of injection (from 47%
among insulin naïve patients to 6% among insulin-
treated patients) was observed [31]. Perhaps, pain antici-
pated by the insulin naïve patients may be exaggerated
compared to the real pain experienced by those who are
using insulin. It is tolerable than they initially expected
[27]. This could explain the drop in fear of insulin injec-
tion despite painful injection. The other reason for fear
of injection is apprehension of self-injection, which was
common (40%) among insulin naïve patients [13,27]. As
insulin injection was found less traumatic than the
patients initially anticipated, this apprehension would
diminish with time resulting in lesser fear of insulin in-
jection [27].
Embarrassment of injection reported by the partici-
pants in this study was also found significant by Snoek
et al. (2007), in which 23% of the insulin naïve patients
admitted that injecting insulin was embarrassing as
compared to 10% of insulin-treated patients [31]. Due to
difference in culture, more insulin naïve patients in
Malaysia (55.9%) described such embarrassment [15]. In
the study by Nur Azmiah et al. (2011), 64.9% of insulin
naïve patients who were not willing to be on insulin per-
ceived 'injecting is embarrassing', which was significantly
higher than those who were willing (46.7%) [15].
Having wrongly identified as drug addicts by others is
another concern of embarrassment shared by the partici-
pants. It is a common worry among insulin naïve dia-
betics and it is related to the use of syringes and vials
[7,21], which is still common in Malaysia.
In this study, concerns about the impacts of insulin
use on the participants’ life also made them refused in-
sulin in the first place. These worries were substantiated
as almost 50% of diabetes patients on insulin felt that its
use restricted their life [12,15,18]. In fact, one third ofinsulin users had difficulties in fulfilling their work and
personal responsibilities [16]. Wong et al. (2011) sug-
gested that this factor could reflect their lower self-
efficacy [16], which was also reported by the participants
in this current study.
As injection-related concerns were prevalent among
diabetics, this should be evaluated and addressed appro-
priately by healthcare providers. Many diabetes patients
prefer more effective insulin with fewer side effects (e.g.
insulin analogues) and new insulin-delivery devices (e.g.
prefilled insulin pens with shorter needles) that are less
invasive and more convenient [32,33]. This insulin has
been found to provide greater lifestyle flexibility, reduce
social stigma and needle phobia, as well as improve self-
efficacy and compliance [32,34-37]. Thus, its use should
always be considered to alleviate injection-related
concerns.
Distorted belief and misconceptions about insulin held
by the participants in the current study were similar to
previous studies [13,15,38]. These studies found in-
creased PIR if the patients believed that insulin could
worsen diabetes or cause complications [13,15]. This is
similar to our participants’ belief that insulin could cause
organ damage. They also thought insulin was for severe
diabetes and they were in denial regarding their diabetes
control, which was similarly found in Funnel (2008) [38].
However, Nur Azmiah et al. (2011) found that, as the
patients’ perceived disease severity increased, their likeli-
hood for PIR increased as well [15]. This is contrary to
the Health Belief Model that posits higher tendency for
patients to change their health behaviour (in this context
is to use insulin) if they believe they have more severe
disease [39]. These misconceptions could reflect the par-
ticipants’ poor knowledge regarding diabetes and insulin
when they were first recommended for insulin [9]. A
qualitative study done in Malaysia by Mohd Ali and Jusoff
(2009) found that majority of their diabetes patients lacked
understanding about diabetes, its management, and the ef-
fects of treatment [40]. Thus, early education at the point
of diagnosis regarding the progressive nature of diabetes
and inevitable use of insulin could allay their misconcep-
tions [9,10]. Therefore, healthcare providers must be pre-
pared with adequate information and counselling skill to
ensure the delivery of diabetic education is effective and
individualised to the patients’ needs [41].
After initiation of insulin, the participants’ active effort
to seek for knowledge on diabetes and its treatment
might contribute to their insulin acceptance. Their good
level of knowledge may be responsible for their renewed
concerns and beliefs that favour insulin use [14,23]. Bet-
ter understanding about the disease could also equip pa-
tients with higher self-efficacy to manage their diabetes
[40]. As there is various knowledge-seeking methods
found to be practiced by the participants in this study,
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treatment should be provided through multiple strat-
egies (e.g. one-stop centre, website or pamphlets) to en-
hance insulin acceptance. This support can be provided
by trained nurses and it can reduce time constrain to
initiate insulin experienced by physicians [41].
Experiential learning through observing others coping
with insulin use and having benefits of insulin had
helped the participants to alleviate their negative con-
cerns and misconceptions about insulin. Support from
relatives and friends who used insulin had promoted
their insulin acceptance. These findings were concurrent
with Hunt et al. (1997) showed that previous personal
experience, observations and interaction with other in-
fluence ones’ attitude towards insulin [22]. Perhaps, the
aforementioned factors were the reason why those with
more insulin-using relatives were more likely to accept
insulin [14,23]. In view of these, peer support group may
be effective to promote insulin acceptance among insulin
naive diabetics as peer testimonies could facilitate insu-
lin initiation and intensification [10,41].
Apart from these, the participants’ personal experience
using insulin had resulted in strong belief in insulin
benefits and self-efficacy in using insulin. They experi-
enced at first-hand the benefits of insulin in improving
their health, well being, and their glycemic control, as
similarly found in Morris et al. (2005) and Phillips
(2007) [24,27]. Perhaps, they also thought that insulin
use was less traumatic then they initially anticipated as
claimed by the diabetes patients in Phillips (2007) [27].
As a result, the experience helped them to continue
insulin use despite having some reluctance in the begin-
ning [24,26]. In fact, those who had experienced using
insulin would have improved self-efficacy and better
understanding about diabetes [27]. Therefore, ‘trial of in-
sulin’ can be promoted to diabetes patients to provide
them the opportunity to gain such positive experience.
Before the trial, demonstration of insulin device, its nee-
dle and injection technique should be provided [42].
During the demonstration, healthcare providers should
allow the patients to touch the device and try injecting
themselves with placebo [42].
Apart from the participants’ experience in using insu-
lin, practical and emotional support from physicians had
helped them to accept insulin and become more self-
efficient to use insulin. These findings emphasise the im-
portance of good, trust and respect relationship between
patients and healthcare providers. This relationship was
claimed achievable through effective communication
and patient-centred approach. Good interaction and
interpersonal relationship between patients and their
healthcare providers had been found to be the main pro-
moters for insulin use in previous studies [22,23,26]. In
addition, easy access support and quality relationshipwith the healthcare providers could increase patients’
knowledge, self-efficacy, greater general well-being, lesser
diabetes-related distress, and better adherence to self-
care activities (lifestyle and medication regimens) [43].
However, dominance of healthcare providers in making
decision to initiate insulin for their patients, as observed
in Phillip (2007) and Morris et al. (2005) [24,27], should
be avoided. This is because informing patients about
their treatment options and involving them in making
treatment decisions could improve their adherence to
the opted treatment [43]. Thus, regular training in effect-
ive communication for healthcare providers is undeni-
ably crucial.
Limitations of this study are mostly related to its
design. This study involved only those from an urban
clinic, thus generalisation of findings should be done
cautiously. In addition, recall bias might be possible as
selected participants were those who had been on insu-
lin at least for more than a year. For future study, ex-
ploring ambivalence to use insulin among those who
have been recently initiated insulin by their healthcare
providers is recommended. This could provide further
information about their decision making process.
Conclusions
Patients’ concerns and beliefs regarding insulin use are
very much influenced by their knowledge, experience
and support from others. Thus it is crucial to provide
them with knowledge (through effective communication,
support and educational activities), as well as positive
experience for them to adopt favourable concerns and
beliefs that promote insulin acceptance. In addition,
delivering patient-centred care and good doctor-patient
relationship will contribute to achieving long term treat-
ment targets to both the patient and physician.
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